• Guideline Summary
  • NGC:009518
  • 2012 Dec

Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma.

  • Guideline Summary
  • NGC:010348
  • 2014 Apr

Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer.

  • Guideline Summary
  • NGC:010700
  • 2014 Sep 30

Optimal systemic therapy for early female breast cancer.

  • Guideline Summary
  • NGC:011064
  • 2016 Jun 8

Clinical utility of multigene profiling assays in invasive early-stage breast cancer.

  • Guideline Summary
  • NGC:009587
  • 2012 Apr (reaffirmed 2014)

Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and abacavir dosing.

  • Guideline Summary
  • NGC:010419
  • 2014 May

The management of women with red cell antibodies during pregnancy.

  • Guideline Summary
  • NGC:010590
  • 2012 Jul (revised 2014 Oct)

The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

  • Guideline Summary
  • NGC:010502
  • 2014 Jun

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.

  • Guideline Summary
  • NGC:010882
  • 2015 Aug

Systemic therapy for unresectable stage III or metastatic cutaneous melanoma.